A novel obestatin analogue with enhanced biological stability attenuates endothelial dysfunction and hypertension in angiotensin II– treated rats

Andrew Agnew; Olivier Chevallier; Brett Greer; David Grieve; Brian Green

A novel obestatin analogue with enhanced biological stability attenuates endothelial dysfunction and hypertension in angiotensin II– treated rats

Andrew Agnew
, Olivier Chevallier
, Brett Greer
, David Grieve
, Brian Green

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Published - 2011
Event	Diabetes UK Annual Professional Conference, London - London, United Kingdom Duration: 01 Mar 2011 → …

Conference

Conference	Diabetes UK Annual Professional Conference, London
Country/Territory	United Kingdom
City	London
Period	01/03/2011 → …

Cite this

@conference{459a184679934dfc9b03045c10285738,

title = "A novel obestatin analogue with enhanced biological stability attenuates endothelial dysfunction and hypertension in angiotensin II– treated rats",

author = "Andrew Agnew and Olivier Chevallier and Brett Greer and David Grieve and Brian Green",

year = "2011",

language = "English",

note = "Diabetes UK Annual Professional Conference, London ; Conference date: 01-03-2011",

}

A novel obestatin analogue with enhanced biological stability attenuates endothelial dysfunction and hypertension in angiotensin II– treated rats. / Agnew, Andrew; Chevallier, Olivier; Greer, Brett et al.
2011. Abstract from Diabetes UK Annual Professional Conference, London, London, United Kingdom.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - A novel obestatin analogue with enhanced biological stability attenuates endothelial dysfunction and hypertension in angiotensin II– treated rats

AU - Agnew, Andrew

AU - Chevallier, Olivier

AU - Greer, Brett

AU - Grieve, David

AU - Green, Brian

PY - 2011

Y1 - 2011

M3 - Abstract

T2 - Diabetes UK Annual Professional Conference, London

Y2 - 1 March 2011

ER -